---
figid: PMC5975367__nihms966579f3
figlink: /pmc/articles/PMC5975367/figure/F3/
number: F3
caption: Pre-clinical and clinical models have indicated that the tumor microenvironment,
  for example pancreatic stellate cells in the case of pancreatic cancer, p53 status,
  RAS family status, activation of JAK–STAT and PI3K signaling may all play roles
  in the determination of autophagy dependence within cancer cells, both in vitro
  and in patients. These pathways have all been shown to affect autophagy either positively
  or negatively and many participate in cross-pathway signaling. Signaling through
  p53 can both promote and inhibit autophagy and may interact with other proteins
  activated by mutations to enhance autophagy dependence, especially in pancreatic
  cancer. Activation of EGFR via amplification or mutation leads to the downstream
  up-regulation of the PI3K-AKT-mTOR pathway as well as activation of STAT3 and the
  RAS pathway. Although autophagy inhibition can occur through mTOR activation, these
  downstream effects collectively result in stimulation of autophagy and an increase
  in autophagy dependence. Mutations or alterations in the RAS family (specifically
  KRAS) have been shown to promote autophagy, enhancing tumor growth and therapy resistance.
  Specific mutations in RAF such as BRAFV600E promote autophagy dependence in multiple
  tumors including central nervous system (CNS) tumors and melanoma. Finally, autophagy
  regulation of JAK-STAT signaling through IL-6 has been identified as a mechanism
  of autophagy dependence in breast cancer. All of these pathways are complex and
  interact on multiple levels. Identification of tumors with these pathways and as
  of yet to be identified pathways will provide methods of detection of autophagy
  dependent tumors.
pmcid: PMC5975367
papertitle: Targeting Autophagy in Cancer.
reftext: Jean M. Mulcahy Levy, et al. Nat Rev Cancer. ;17(9):528-542.
pmc_ranked_result_index: '34099'
pathway_score: 0.9366712
filename: nihms966579f3.jpg
figtitle: Targeting Autophagy in Cancer
year: ''
organisms: Homo sapiens
ndex: cf19c8ac-df07-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5975367__nihms966579f3.html
  '@type': Dataset
  description: Pre-clinical and clinical models have indicated that the tumor microenvironment,
    for example pancreatic stellate cells in the case of pancreatic cancer, p53 status,
    RAS family status, activation of JAK–STAT and PI3K signaling may all play roles
    in the determination of autophagy dependence within cancer cells, both in vitro
    and in patients. These pathways have all been shown to affect autophagy either
    positively or negatively and many participate in cross-pathway signaling. Signaling
    through p53 can both promote and inhibit autophagy and may interact with other
    proteins activated by mutations to enhance autophagy dependence, especially in
    pancreatic cancer. Activation of EGFR via amplification or mutation leads to the
    downstream up-regulation of the PI3K-AKT-mTOR pathway as well as activation of
    STAT3 and the RAS pathway. Although autophagy inhibition can occur through mTOR
    activation, these downstream effects collectively result in stimulation of autophagy
    and an increase in autophagy dependence. Mutations or alterations in the RAS family
    (specifically KRAS) have been shown to promote autophagy, enhancing tumor growth
    and therapy resistance. Specific mutations in RAF such as BRAFV600E promote autophagy
    dependence in multiple tumors including central nervous system (CNS) tumors and
    melanoma. Finally, autophagy regulation of JAK-STAT signaling through IL-6 has
    been identified as a mechanism of autophagy dependence in breast cancer. All of
    these pathways are complex and interact on multiple levels. Identification of
    tumors with these pathways and as of yet to be identified pathways will provide
    methods of detection of autophagy dependent tumors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MDM2
  - EGF
  - PIK3CB
  - EGFR
  - MAPK1
  - JUN
  - MAP2K1
  - PIK3CD
  - MDM4
  - TYK2
  - SLC25A1
  - IL6R
  - JAK1
  - CUX1
  - JAK3
  - SHC4
  - MAPK3
  - JAK2
  - FOXO1
  - AKT3
  - MAP2K2
  - FOXO6
  - ATM
  - BRAF
  - HRAS
  - KRAS
  - NRAS
  - SHC2
  - PIK3CA
  - AKT1
  - SHC3
  - SHC1
  - FOXO3
  - CHUK
  - AKT2
  - MTOR
  - FOXO4
  - PIK3CG
  - PIK3R5
  - PIK3R6
  - PIK3R4
  - TP53
  - PIK3R3
  - PTEN
  - ARAF
  - STAT3
  - RAF1
  - CDP
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Melanoma
  - Noonan syndrome
genes:
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: JUN
  symbol: JUN
  source: hgnc_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: (MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: (MDMX)
  symbol: MDMX
  source: hgnc_alias_symbol
  hgnc_symbol: MDM4
  entrez: '4194'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: ČTP
  symbol: CTP
  source: hgnc_alias_symbol
  hgnc_symbol: SLC25A1
  entrez: '6576'
- word: IL-6R
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: CDP
  symbol: CDP
  source: hgnc_alias_symbol
  hgnc_symbol: CUX1
  entrez: '1523'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: (MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: ATM
  symbol: ATM
  source: hgnc_symbol
  hgnc_symbol: ATM
  entrez: '472'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: IKKa
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: P53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
chemicals:
- word: CDP
  source: MESH
  identifier: D003565
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Melanoma
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5975367__F3
redirect_from: /figures/PMC5975367__F3
figtype: Figure
---
